Amy Hough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amy Hough has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- John Wright
Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
4 shared publications - Dan Mason
Bradford Institute for Health Research Bradford England BD9 6RJ Bradford Royal Infirmary
3 shared publications - Armando Mendez-Villalon
Co-Connect, University of Nottingham, University Park, England
2 shared publications - Arturo Gonzalez-Izquierdo
Department of Applied Health Sciences, University of Birmingham, Birmingham, UK
2 shared publications - Carlos Sánchez-Soriano
Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
2 shared publications Daniel S. Malawsky
Human Genetics Hinxton England CB10 1SA Wellcome Sanger Institute
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 1005
Prevalence of alcohol, cigarettes, drugs, and vaping among adolescents in Bradford, England: evidence from the Born in Bradford Age of Wonder study
Background This study examines the prevalence of alcohol, cigarettes, drugs and vaping among secondary school pupils in Bradford, a city characterised by high levels of ethnic diversity and socioeconomic deprivation. Methods A cross-sectional analysis was conducted using data collected during the 2023/2024 and 2024/2025 academic year, as part of the Age of Wonder study. Self-reported surveys were completed by 13,143 participants in Years 8-10 (aged 12-15) across 25 secondary schools. We estimated the prevalence of experimentation and frequency of use for nicotine, alcohol, and illicit drugs, stratified by ethnicity and deprivation. This is supplemented by qualitative interviews, group discussions and creative expressions from 106 young people taking part in qualitative longitudinal research as part of Age of Wonder. Results Alcohol was the most prevalent substance of experimentation (20.4%), closely followed by vaping (19.6%). Cigarette smoking experimentation was lower, at 5.4%. Among illicit drugs, 3.2% had tried cannabis, 1.1% nitrous oxide, 0.7% ecstasy, and 0.6% ketamine. The sample was highly diverse (44.2% Asian/Asian British) and socioeconomically challenged (59.7% in the most deprived quintile of neighbourhoods nationally). Young people taking part in qualitative research suggested high prevalence and normalisation of vaping, with limited emphasis on use of alcohol, cigarettes or illicit drugs. Conclusions Alcohol and vaping are the primary substances tried by adolescents in Bradford. The distinct demographic profile of the city may offer protective factors and contribute the lower prevalence of substance use than adolescents nationally.
- 16 November 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 1005
Open AccessPrevalence of alcohol, cigarettes, drugs, and vaping among adolescents in Bradford, England: evidence from the Born in Bradford Age of Wonder study
Background This study examines the prevalence of alcohol, cigarettes, drugs and vaping among secondary school pupils in Bradford, a city characterised by high levels of ethnic diversity and socioeconomic deprivation. Methods A cross-sectional analysis was conducted using data collected during the 2023/2024 and 2024/2025 academic year, as part of the Age of Wonder study. Self-reported surveys were completed by 13,143 participants in Years 8-10 (aged 12-15) across 25 secondary schools. We estimated the prevalence of experimentation and frequency of use for nicotine, alcohol, and illicit drugs, stratified by ethnicity and deprivation. This is supplemented by qualitative interviews, group discussions and creative expressions from 106 young people taking part in qualitative longitudinal research as part of Age of Wonder. Results Alcohol was the most prevalent substance of experimentation (20.4%), closely followed by vaping (19.6%). Cigarette smoking experimentation was lower, at 5.4%. Among illicit drugs, 3.2% had tried cannabis, 1.1% nitrous oxide, 0.7% ecstasy, and 0.6% ketamine. The sample was highly diverse (44.2% Asian/Asian British) and socioeconomically challenged (59.7% in the most deprived quintile of neighbourhoods nationally). Young people taking part in qualitative research suggested high prevalence and normalisation of vaping, with limited emphasis on use of alcohol, cigarettes or illicit drugs. Conclusions Alcohol and vaping are the primary substances tried by adolescents in Bradford. The distinct demographic profile of the city may offer protective factors and contribute the lower prevalence of substance use than adolescents nationally.
- Open Access
Mother-infant linked UK electronic birth cohorts representing 17.5 million births harmonised to the OMOP common data model
We describe the harmonisation of five UK electronic birth cohorts to the Observational Medical Outcomes Partnership (OMOP) Common Data Model, creating a large-scale, standardised resource for maternal and child health research. The Mother and Infant Research Data Analysis (MIREDA) partnership developed and implemented reproducible guidelines for mapping maternal–infant relationships and identifying pregnancy episodes within routinely collected healthcare data. Cohorts from England, Scotland, and Wales were transformed despite substantial heterogeneity in data structure, coding systems, and variable definitions. The resulting harmonised resource preserves each cohort as an independent dataset while enabling federated analyses to be conducted across sites without the need to share individual-level data. Collectively, the cohorts capture over 17.5 million live births, providing sufficient scale to investigate rare exposures and outcomes, support trial emulation, and evaluate population-level policy impacts across the UK. This article details the transformation pipeline and provides reusable methods to support extension to additional cohorts and networks. The harmonised datasets enable interoperable, reproducible research and facilitate cross-national comparative studies in maternal and child health.
Open AccessMother-infant linked UK electronic birth cohorts representing 17.5 million births harmonised to the OMOP common data model
We describe the harmonisation of five UK electronic birth cohorts to the Observational Medical Outcomes Partnership (OMOP) Common Data Model, creating a large-scale, standardised resource for maternal and child health research. The Mother and Infant Research Data Analysis (MIREDA) partnership developed and implemented reproducible guidelines for mapping maternal–infant relationships and identifying pregnancy episodes within routinely collected healthcare data. Cohorts from England, Scotland, and Wales were transformed despite substantial heterogeneity in data structure, coding systems, and variable definitions. The resulting harmonised resource preserves each cohort as an independent dataset while enabling federated analyses to be conducted across sites without the need to share individual-level data. Collectively, the cohorts capture over 17.5 million live births, providing sufficient scale to investigate rare exposures and outcomes, support trial emulation, and evaluate population-level policy impacts across the UK. This article details the transformation pipeline and provides reusable methods to support extension to additional cohorts and networks. The harmonised datasets enable interoperable, reproducible research and facilitate cross-national comparative studies in maternal and child health.
- Open Access
- 5 December 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 390
Exome sequencing of UK birth cohorts
Birth cohort studies involve repeated surveys of large numbers of individuals from birth and throughout their lives. They collect information useful for a wide range of life course research domains, and biological samples which can be used to derive data from an increasing collection of omic technologies. This rich source of longitudinal data, when combined with genomic data, offers the scientific community valuable insights ranging from population genetics to applications across the social sciences. Here we present quality-controlled whole exome sequencing data from three UK birth cohorts: the Avon Longitudinal Study of Parents and Children (8,436 children and 3,215 parents), the Millenium Cohort Study (7,667 children and 6,925 parents) and Born in Bradford (8,784 children and 2,875 parents). The overall objective of this coordinated effort is to make the resulting high-quality data widely accessible to the global research community in a timely manner. We describe how the datasets were generated and subjected to quality control at the sample, variant and genotype level. We then present some preliminary analyses to illustrate the quality of the datasets and probe potential sources of bias. We introduce measures of ultra-rare variant burden to the variables available for researchers working on these cohorts, and show that the exome-wide burden of deleterious protein-truncating variants, S het burden, is associated with educational attainment and cognitive test scores. The whole exome sequence data from these birth cohorts (CRAM & VCF files) are available through the European Genome-Phenome Archive, and here we provide guidance for their use.
- 5 December 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 390
Open AccessExome sequencing of UK birth cohorts
Birth cohort studies involve repeated surveys of large numbers of individuals from birth and throughout their lives. They collect information useful for a wide range of life course research domains, and biological samples which can be used to derive data from an increasing collection of omic technologies. This rich source of longitudinal data, when combined with genomic data, offers the scientific community valuable insights ranging from population genetics to applications across the social sciences. Here we present quality-controlled whole exome sequencing data from three UK birth cohorts: the Avon Longitudinal Study of Parents and Children (8,436 children and 3,215 parents), the Millenium Cohort Study (7,667 children and 6,925 parents) and Born in Bradford (8,784 children and 2,875 parents). The overall objective of this coordinated effort is to make the resulting high-quality data widely accessible to the global research community in a timely manner. We describe how the datasets were generated and subjected to quality control at the sample, variant and genotype level. We then present some preliminary analyses to illustrate the quality of the datasets and probe potential sources of bias. We introduce measures of ultra-rare variant burden to the variables available for researchers working on these cohorts, and show that the exome-wide burden of deleterious protein-truncating variants, S het burden, is associated with educational attainment and cognitive test scores. The whole exome sequence data from these birth cohorts (CRAM & VCF files) are available through the European Genome-Phenome Archive, and here we provide guidance for their use.
- Open Access
- 29 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (48) , eadr2084
Cesarean delivery and blood DNA methylation at birth and childhood: Meta-analysis in the Pregnancy and Childhood Epigenetics Consortium
Children born via cesarean delivery have a higher risk of metabolic, immunological, and neurodevelopmental disorders compared to those born via vaginal delivery, although mechanisms remain unclear. We conducted a meta-analysis of epigenome-wide association studies to examine the associations between delivery mode and blood DNA methylation at birth and its persistence in early childhood. Participants were from 19 pregnancy cohorts (9833 term newborns) and 6 pediatric cohorts (2429 children aged 6 to 10 years). We identified six CpGs in cord blood associated with cesarean delivery (effect size range: 0.4 to 0.7%, P < 1.0 × 10 −7 ): MAP2K2 (cg19423175), LIM2 (cg01500140), CNP (cg13917614), BLM (cg18247172), RASA3 (cg22348356), and RUNX3 (cg20674490), independent of cell proportions and other confounders. In childhood, none of these CpGs were associated with cesarean delivery, and no additional CpGs were identified. Delivery mode was associated with cell proportions at birth but not in childhood. Further research is needed to elucidate cesarean delivery’s molecular influence on offspring health.
- 29 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (48) , eadr2084
Open AccessCesarean delivery and blood DNA methylation at birth and childhood: Meta-analysis in the Pregnancy and Childhood Epigenetics Consortium
Children born via cesarean delivery have a higher risk of metabolic, immunological, and neurodevelopmental disorders compared to those born via vaginal delivery, although mechanisms remain unclear. We conducted a meta-analysis of epigenome-wide association studies to examine the associations between delivery mode and blood DNA methylation at birth and its persistence in early childhood. Participants were from 19 pregnancy cohorts (9833 term newborns) and 6 pediatric cohorts (2429 children aged 6 to 10 years). We identified six CpGs in cord blood associated with cesarean delivery (effect size range: 0.4 to 0.7%, P < 1.0 × 10 −7 ): MAP2K2 (cg19423175), LIM2 (cg01500140), CNP (cg13917614), BLM (cg18247172), RASA3 (cg22348356), and RUNX3 (cg20674490), independent of cell proportions and other confounders. In childhood, none of these CpGs were associated with cesarean delivery, and no additional CpGs were identified. Delivery mode was associated with cell proportions at birth but not in childhood. Further research is needed to elucidate cesarean delivery’s molecular influence on offspring health.
- Open Access
- 19 July 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 390
Exome sequencing of UK birth cohorts
Birth cohort studies involve repeated surveys of large numbers of individuals from birth and throughout their lives. They collect information useful for a wide range of life course research domains, and biological samples which can be used to derive data from an increasing collection of omic technologies. This rich source of longitudinal data, when combined with genomic data, offers the scientific community valuable insights ranging from population genetics to applications across the social sciences. Here we present quality-controlled whole exome sequencing data from three UK birth cohorts: the Avon Longitudinal Study of Parents and Children (8,436 children and 3,215 parents), the Millenium Cohort Study (7,667 children and 6,925 parents) and Born in Bradford (8,784 children and 2,875 parents). The overall objective of this coordinated effort is to make the resulting high-quality data widely accessible to the global research community in a timely manner. We describe how the datasets were generated and subjected to quality control at the sample, variant and genotype level. We then present some preliminary analyses to illustrate the quality of the datasets and probe potential sources of bias. We introduce measures of ultra-rare variant burden to the variables available for researchers working on these cohorts, and show that the exome-wide burden of deleterious protein-truncating variants, S het burden, is associated with educational attainment and cognitive test scores. The whole exome sequence data from these birth cohorts (CRAM & VCF files) are available through the European Genome-Phenome Archive, and here provide guidance for their use.
- 19 July 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 390
Open AccessExome sequencing of UK birth cohorts
Birth cohort studies involve repeated surveys of large numbers of individuals from birth and throughout their lives. They collect information useful for a wide range of life course research domains, and biological samples which can be used to derive data from an increasing collection of omic technologies. This rich source of longitudinal data, when combined with genomic data, offers the scientific community valuable insights ranging from population genetics to applications across the social sciences. Here we present quality-controlled whole exome sequencing data from three UK birth cohorts: the Avon Longitudinal Study of Parents and Children (8,436 children and 3,215 parents), the Millenium Cohort Study (7,667 children and 6,925 parents) and Born in Bradford (8,784 children and 2,875 parents). The overall objective of this coordinated effort is to make the resulting high-quality data widely accessible to the global research community in a timely manner. We describe how the datasets were generated and subjected to quality control at the sample, variant and genotype level. We then present some preliminary analyses to illustrate the quality of the datasets and probe potential sources of bias. We introduce measures of ultra-rare variant burden to the variables available for researchers working on these cohorts, and show that the exome-wide burden of deleterious protein-truncating variants, S het burden, is associated with educational attainment and cognitive test scores. The whole exome sequence data from these birth cohorts (CRAM & VCF files) are available through the European Genome-Phenome Archive, and here provide guidance for their use.
- Open Access
- 24 June 2024
- Published by Elsevier in Environment International
- Vol. 190, 108845
Common genetic variants associated with urinary phthalate levels in children: A genome-wide study
- 24 June 2024
- Published by Elsevier in Environment International
- Vol. 190, 108845
Open AccessCommon genetic variants associated with urinary phthalate levels in children: A genome-wide study
- Open Access
Maternal and Infant Research Electronic Data Analysis (MIREDA): A protocol for creating a common data model for federated analysis of UK birth cohorts and the life course
Introduction Birth cohorts are valuable resources for studying early life, the determinants of health, disease, and development. They are essential for studying life course. Electronic cohorts are live, dynamic longitudinal cohorts using anonymised, routinely collected data. There is no selection bias through direct recruitment, but they are limited to health and administrative system data and may lack contextual information. The MIREDA (Maternal and Infant Research Electronic Data Analysis) partnership creates a UK-wide birth cohort by aligning existing electronic birth cohorts to have the same structure, content, and vocabularies, enabling UK-wide federated analyses. Objectives Create a core dynamic, live UK-wide electronic birth cohort with approximately 100,000 new births per year using a common data model (CDM). Provide data linkage and automation for long-term follow up of births from MuM-PreDiCT and the ‘Born in’ initiatives of Bradford, Wales, Scotland, and South London for comparable analyses. Methods We will establish core data content and collate linkable data. Use a suite of extraction, transformation, and load (ETL) tools will be used to transform the data for each birth cohort into the CDM. Transformed datasets will remain within each cohort’s trusted research environment (TRE). Metadata will be uploaded for the public to the Health Data Research (HDRUK) Innovation Gateway. We will develop a single online data access request for researchers. A cohort profile will be developed for researchers to reference the resource. Ethics Each cohort has approval from their TRE through compliance with their project application processes and information governance. Dissemination We will engage with researchers in the field to promote our resource through partnership networking, publication, research collaborations, conferences, social media, and marketing communications strategies.
Open AccessMaternal and Infant Research Electronic Data Analysis (MIREDA): A protocol for creating a common data model for federated analysis of UK birth cohorts and the life course
Introduction Birth cohorts are valuable resources for studying early life, the determinants of health, disease, and development. They are essential for studying life course. Electronic cohorts are live, dynamic longitudinal cohorts using anonymised, routinely collected data. There is no selection bias through direct recruitment, but they are limited to health and administrative system data and may lack contextual information. The MIREDA (Maternal and Infant Research Electronic Data Analysis) partnership creates a UK-wide birth cohort by aligning existing electronic birth cohorts to have the same structure, content, and vocabularies, enabling UK-wide federated analyses. Objectives Create a core dynamic, live UK-wide electronic birth cohort with approximately 100,000 new births per year using a common data model (CDM). Provide data linkage and automation for long-term follow up of births from MuM-PreDiCT and the ‘Born in’ initiatives of Bradford, Wales, Scotland, and South London for comparable analyses. Methods We will establish core data content and collate linkable data. Use a suite of extraction, transformation, and load (ETL) tools will be used to transform the data for each birth cohort into the CDM. Transformed datasets will remain within each cohort’s trusted research environment (TRE). Metadata will be uploaded for the public to the Health Data Research (HDRUK) Innovation Gateway. We will develop a single online data access request for researchers. A cohort profile will be developed for researchers to reference the resource. Ethics Each cohort has approval from their TRE through compliance with their project application processes and information governance. Dissemination We will engage with researchers in the field to promote our resource through partnership networking, publication, research collaborations, conferences, social media, and marketing communications strategies.